Symptomatic Venous Thromboembolism is Associated with Inferior Survival among Patients Undergoing Nephrectomy with Inferior Vena Cava Tumor Thrombectomy for Renal Cell Carcinoma

[1]  C. Morash,et al.  Current guidelines do not sufficiently discriminate venous thromboembolism risk in urology. , 2017, Urologic oncology.

[2]  R. Matulewicz,et al.  Venous thromboembolism after nephrectomy: incidence, timing and associated risk factors from a national multi-institutional database , 2017, World Journal of Urology.

[3]  N. Smith,et al.  Extended Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy Compared to Inpatient Only Subcutaneous Heparin , 2017, The Journal of urology.

[4]  C. Booth,et al.  Risk factors and timing of venous thromboembolism after radical cystectomy in routine clinical practice: a population‐based study , 2016, BJU international.

[5]  A. Darzi,et al.  Risk of Post-Discharge Venous Thromboembolism and Associated Mortality in General Surgery: A Population-Based Cohort Study Using Linked Hospital and Primary Care Data in England , 2015, PloS one.

[6]  A. Weinberg,et al.  Venous thromboembolism after major urologic oncology surgery: a focus on the incidence and timing of thromboembolic events after 27,455 operations. , 2014, Urology.

[7]  E. D. Thomas,et al.  The survival detriment of venous thromboembolism with epithelial ovarian cancer. , 2014, Gynecologic oncology.

[8]  E. Horváth-Puhó,et al.  30-Year Mortality After Venous Thromboembolism: A Population-Based Cohort Study , 2014, Circulation.

[9]  C. Amling,et al.  Timing, incidence and risk factors for venous thromboembolism in patients undergoing radical cystectomy for malignancy: a case for extended duration pharmacological prophylaxis. , 2014, The Journal of urology.

[10]  G. Ciancio,et al.  Increased risk of preoperative venous thromboembolism in patients with renal cell carcinoma and tumor thrombus: comment , 2014, Journal of thrombosis and haemostasis : JTH.

[11]  E. Wallen,et al.  Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC) , 2014, Current Urology Reports.

[12]  C. Canil,et al.  Increased risk of preoperative venous thromboembolism in patients with renal cell carcinoma and tumor thrombus , 2014, Journal of thrombosis and haemostasis : JTH.

[13]  M. Meng,et al.  Natural history of untreated renal cell carcinoma with venous tumor thrombus. , 2013, Urologic oncology.

[14]  A. Finelli,et al.  Results of a national population-based study of outcomes of surgery for renal tumors associated with inferior vena cava thrombus. , 2013, Urology.

[15]  V. Margulis,et al.  Preoperative pulmonary embolism does not predict poor postoperative outcomes in patients with renal cell carcinoma and venous thrombus. , 2013, The Journal of urology.

[16]  S. Boorjian,et al.  The implications of hospital acquired adverse events on mortality, length of stay and costs for patients undergoing radical cystectomy for bladder cancer. , 2012, The Journal of urology.

[17]  M. McCarter,et al.  Post-Discharge Venous Thromboembolism After Cancer Surgery: Extending the Case for Extended Prophylaxis , 2011, Annals of surgery.

[18]  P. Prandoni,et al.  Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study , 2010, Journal of thrombosis and haemostasis : JTH.

[19]  H. Chew,et al.  The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer , 2010, Cancer.

[20]  L. Demidov,et al.  Hypercoagulability as a prognostic factor for survival in patients with metastatic renal cell carcinoma , 2009, Journal of experimental & clinical cancer research : CR.

[21]  A. Belldegrun,et al.  Intraoperative thrombus embolization during nephrectomy and tumor thrombectomy: critical analysis of the University of California-Los Angeles experience. , 2009, The Journal of urology.

[22]  M. Monreal,et al.  Clinical outcome of patients with major bleeding after venous thromboembolism , 2008, Thrombosis and Haemostasis.

[23]  A. Khorana,et al.  Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients , 2008, Cancer.

[24]  W. Henderson,et al.  Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. , 2007, Journal of vascular surgery.

[25]  P. Russo,et al.  Perioperative clinical thromboembolic events after radical or partial nephrectomy. , 2006, Urology.

[26]  F. Parazzini,et al.  A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer Surgery: The @RISTOS Project , 2006, Annals of surgery.

[27]  A. Cohen,et al.  Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. , 2002, The New England journal of medicine.

[28]  H. Zincke,et al.  Surgical treatment of renal cancer with vena cava extension. , 1987, British journal of urology.

[29]  M. Menon,et al.  Venous thromboembolism after major cancer surgery: temporal trends and patterns of care. , 2014, JAMA surgery.